524
Participants
Start Date
May 31, 2005
Primary Completion Date
October 31, 2017
Study Completion Date
November 15, 2021
rituximab
IV
cyclophosphamide
IV
doxorubicin
IV or CIVI
vincristine
IV or CIVI
prednisone
oral
etoposide
CIVI
filgrastim
IV
pegfilgrastim
IV
New York Weill Cornell Cancer Center at Cornell University, New York
Charles R. Wood Cancer Center at Glens Falls Hospital, Glens Falls
James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester
Easton Regional Cancer Center at Easton Hospital, Easton
Geisinger Hazleton Cancer Center, Hazleton
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center, Wilkes-Barre
CCOP - Christiana Care Health Services, Newark
Alvin and Lois Lapidus Cancer Institute at Sinai Hospital, Baltimore
Mary Babb Randolph Cancer Center at West Virginia University Hospitals, Morgantown
Kinston Medical Specialists, Kinston
Iredell Memorial Hospital, Statesville
Mercy Cancer Center at Mercy Medical Center, Canton
Providence Cancer Institute at Providence Hospital - Southfield Campus, Southfield
Marshfield Clinic - Marshfield Center, Marshfield
Saint Joseph's Hospital, Marshfield
Marshfield Clinic - Weston Center, Weston
Marshfield Clinic at Saint Michael's Hospital, Stevens Point
Saint Michael's Hospital Cancer Center, Stevens Point
Ministry Medical Group at Saint Mary's Hospital, Rhinelander
Marshfield Clinic - Lakeland Center, Minocqua
Marshfield Clinic - Indianhead Center, Rice Lake
Altru Cancer Center at Altru Hospital, Grand Forks
Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood
Creticos Cancer Center at Advocate Illinois Masonic Medical Center, Chicago
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis
Christian Hospital Northeast-Northwest, St Louis
Naval Medical Center - San Diego, San Diego
Camino Medical Group - Treatment Center, Mountain View
Palo Alto Medical Foundation, Palo Alto
Saint Helena Hospital, St. Helena
Madigan Army Medical Center - Tacoma, Tacoma
Rebecca and John Moores UCSD Cancer Center, La Jolla
Eastern Connecticut Hematology and Oncology Associates, Norwich
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
University of Illinois Cancer Center, Chicago
National Naval Medical Center, Bethesda
NIH - Warren Grant Magnuson Clinical Center, Bethesda
New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care, Concord
New Hampshire Oncology - Hematology, PA - Hooksett, Hooksett
Presbyterian Cancer Center at Presbyterian Hospital, Charlotte
Wake Forest University Comprehensive Cancer Center, Winston-Salem
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus
Geisinger Cancer Institute at Geisinger Health, Danville
Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center, Hershey
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital, Pittsburgh
Mountainview Medical, Berlin Corners
Virginia Commonwealth University Massey Cancer Center, Richmond
National Cancer Institute (NCI)
NIH
Alliance for Clinical Trials in Oncology
OTHER